European market focus UNEeg Medical already has the Episight solution commercially available in Europe, indicating a strong regional foothold and potential for expansion into adjacent European markets or sectors that require real-world EEG data.

US market clearance gap The Episight solution is not yet cleared for sales in the US, presenting a clear near-term opportunity for inbound sales efforts targeting regulatory approval milestones, partnerships, or interim pilots to accelerate US market entry.

federal revenue range With current annual revenue in the 1-10 million range and a relatively lean organization, there may be room to scale through channel partnerships, OEM agreements, or medical device distributors to broaden reach without major overhead.

clinical data value Real-world EEG data focus suggests a compelling value proposition for research institutions, clinics, and telehealth platforms seeking brain health therapy insights, enabling cross-selling with data services or analytics add-ons.

growth readiness Small-to-mid sized team size (51-200 employees) and a background in ISO/XML technology stacks position UNEEG for scalable deployments, potential upsell through expanded product features, and participation in pilot programs with larger healthcare networks.